Delivery Order SPE2DB22D1200-SPE2DB25FN3TU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,041.56 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units. Issued on July 21, 2025, with completion scheduled for July 22, 2025, this firm fixed-price contract represents a small-value pharmaceutical supply order to support federal medical procurement needs. The award utilizes no set-aside designation and reflects competitive procurement practices. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $36,033.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of August 18, 2025. The contract, which was competitively awarded with no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units with a ceiling value of $3,038.31. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,479.02 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 15, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order executed on August 14, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The contract is a child award under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,418.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch (30-count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,575.68 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of August 5, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s under a firm fixed-price contract valued at $10,068.42. This non-competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA. The work will be performed at the contractor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,370.05 on August 4, 2025, for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of August 5, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB25FN3TUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,168.83 to AmerisourceBergen Drug Corp for 30-count Lidocaine 5% patches. This competitively awarded, firm fixed-price delivery order was issued on August 12, 2025, with an ultimate completion date of August 13, 2025. The contract represents a non-set-aside procurement, indicating open competition among qualified pharmaceutical vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply a vast range of pharmaceuticals and medical supplies to support military healthcare programs globally. The lidocaine patch procurement supports DLA's medical supply chain operations and contributes to pain management capabilities across the federal healthcare system, including the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/12/25 |